0NWK.LSE Valerio Therapeutics

Healthcare Oil, Gas & Consumable Fuels London Exchange
0.1774 EUR
Close of Oct 16, 2026
0.1060 0.9800
Market cap
EUR 8.98M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2021.

Is 0NWK.LSE undervalued?

Graham number

The Graham number of Valerio Therapeutics cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Valerio Therapeutics fundamental analysis

No fundamental analysis for Valerio Therapeutics yet.

Valerio Therapeutics stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Valerio Therapeutics

Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies. The company develops PlatON, a proprietary chemical platform for DNA decoy therapies, which generates new compounds and broadens its product portfolio; DecoyTAC, a mechanism of action of DNA decoy therapies coupled with targeted protein degradation; and V-body platform, a bispecific T-cell engagers, antibody" drug conjug…

Full company profile